跳至主要内容
临床试验/NCT04380610
NCT04380610已完成不适用

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

University of Alabama at Birmingham4 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
4
主要终点
To develop a novel SCA-specific eGFR equation and compare with existing eGFR equations validated for the general population

研究概览

简要总结

The investigators will attempt to develop a more accurate equation to estimate eGFR in pediatric and adult sickle cell patients

详细描述

200 pediatric and 200 adult SCA participants will undergo mGFR using iohexol at baseline and at one year. On the same day, participants will undergo clinical and laboratory variables important for developing an eGFR equation. From baseline data, the investigators will perform a training and validation cohort of biologically relevant predictor variables to develop a novel equation. Then the investigators will compare the novel SCA eGFR equation to the established eGFR equation. From one year data, the investigators will determine the longitudinal concordance between pediatric and adult novel and standard eGFR equations with mGFR and variables that may alter longitudinal inferences.

In a subset of 30 adult participants, the investigators will also evaluate the correlation between mGFR using iohexol and a novel measure of mGFR that is more time efficient

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
5 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • SCA patients (HbSS and SB0 thalassemia)
  • Age: 5.0-50.0 at enrollment

排除标准

  • Recent SCA complication associated with hospitalization (within 30 days) or ED visit (within 14 days)
  • Current AKI defined as >0.3mg/g increase in SCr from prior visit
  • Known history of anaphylaxis with contrast agent or known pregnancy

结局指标

主要结局

To develop a novel SCA-specific eGFR equation and compare with existing eGFR equations validated for the general population

时间窗: 5 years

The investigators will use biologically relevant variables to develop a new equation for eGFR in pediatric and adult sickle cell patients

次要结局

  • To determine the longitudinal concordance between pediatric and adult novel and standard eGFR equations with mGFR and variables that may alter longitudinal inferences.(5 years)
  • To test the correlation of the novel mGFR method using VFI FAST and iohexol mGFR.(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey D. Lebensburger, DO

PI

University of Alabama at Birmingham

研究点 (4)

Loading locations...

相似试验